... FDA Approval of Inlexzo (Gemcitabine Intravesical System) Set To Transform How Certain Bladder Cancers Are Treated — Johnson & Johnson ...
... Inlexzo delivers gemcitabine directly into the bladder via a system that remains in place for three weeks before removal and is typically given once every three weeks for six months, then once every 12 weeks. ...